Dysarthria News and Research

RSS

Smartwatch app to track social interactions of stroke survivors may help maximize recovery

A smartwatch app designed to measure social interactions of hospitalized stroke survivors may enable new treatments to preserve or enhance cognition, social engagement and quality of life after a stroke, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2026.

29 Jan 2026

Wearable AI device turns silent throat signals into fluent speech for stroke patients

AI technology in a wearable choker helps stroke survivors overcome communication barriers by transforming throat vibrations into clear, context-aware speech.

21 Jan 2026

Wearable device enables natural speech in stroke patients with dysarthria

Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the need for invasive brain implants.

19 Jan 2026

New AI model detects early neurological disorders through speech

Recently, the research team led by Prof. Li Hai at the Institute of Health and Medical Technology, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed a novel deep learning framework that significantly improves the accuracy and interpretability of detecting neurological disorders through speech.

29 Aug 2025

Speech recognition technology shows significant gains for people with dysarthria

As Mark Hasegawa-Johnson combed through data from his latest project, he was pleasantly surprised to uncover a recipe for Eggs Florentine. Sifting through hundreds of hours of recorded speech will unearth a treasure or two, he said.

27 Sep 2024

LSVT LOUD outperforms NHS speech and language therapy for people with Parkinson's disease

An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson's disease, finds a trial published in The BMJ today.

11 Jul 2024

Dangerous weight loss trend triggers Iatrogenic botulism outbreak in Europe

Researchers study documents relevant laboratory and epidemiological data on travel-associated iatrogenic botulism outbreaks in Europe.

11 Jun 2023

Deep brain stimulation as obsessive-compulsive disorder treatment

In a recent study published in the Journal of Neurology, Neurosurgery & Psychiatry, researchers investigated the effectiveness of deep brain stimulation (DBS) against treatment-resistant obsessive-compulsive disorder (OCD).

25 Sep 2022

Study explores experiences of speech and language therapists using voice-assisted technology

JMIR Publications recently published "Speech and Language Practitioners' Experiences of Commercially Available Voice-Assisted Technology: Web-Based Survey Study" in JMIR Rehabilitation and Assistive Technologies which reported the professional experiences of UK speech and language therapists using voice-assisted technology (VAT) (e.g. Alexa, Siri) with their clients to identify the potential applications and barriers to VAT adoption and thereby inform future directions of research.

2 Aug 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

1 Nov 2021

Study uncovers rare genetic syndrome caused by mutations in gene SATB1

Advances in DNA sequencing have uncovered a rare syndrome which is caused by variations in the gene SATB1.

28 Jan 2021

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

A research team from Kumamoto University, Japan has developed an animal model that reproduces motor dysfunction and cerebellar neurodegeneration similar to that in spinocerebellar ataxia (SCA) by inhibiting chaperone-mediated autophagy (CMA) in cerebellar neurons.

23 Sep 2020

Hereditary spastic paraplegia characteristics unveiled

Researchers have detailed the characteristics of a large cohort of patients with hereditary spastic paraplegias.

15 Feb 2016

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.

20 Aug 2015

Study explores prevalence of chronic brain damage in retired NFL players

A study published online today in Sports Health: A Multidisciplinary Approach provides a different take on previous information regarding the prevalence of chronic brain damage in retired NFL players.

26 Jun 2014

Communication for people with impaired speech: an interview with Professor Mark Hawley, Professor of Health Services Research, Director of CATCH and lead researcher for VIVOCA

There are many different causes of speech impairment but the one we are particularly interested in is actually the most common cause of speech impediment, which is dysarthria.

5 Feb 2014